Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance)
- Citation:
- Blood Adv vol 2 (14) 1705-18
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 7
- Parents:
- 2681
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Leukemia
- Sec. Committees:
- Leuk Corr Sci
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA025224, U10CA180790, U10CA180820; CCTG: NCTN CA180863 and CCSRI 704970; ECOG-ACRIN: U10CA180791, U10CA180799, and U10CA180802; SWOG: U10CA180888 and U10CA180828; R03 CA186183-02
- Corr. Author:
- Authors:
- John C. Byrd Amy S. Ruppert Nyla A. Heerema Alese E. Halvorson Eva Hoke Mitchell R. Smith John E. Godwin Stephen Couban Todd A. Fehniger Michael J. Thirman Martin S. Tallman Frederick R. Appelbaum Richard M. Stone Sue Robinson Julie E. Chang Sumithra J. Mandrekar Richard A. Larson
- Networks:
- LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-OH007, LAPS-WI020, OH070, PCRC
- Study
- CALGB-10404
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: